1. Acetaldehyde, Acetaldehyde Metabolism, and Risk of Cancers {#sec1-ijms-18-01943}
=============================================================

Acetaldehyde, a low molecular weight organic aldehyde with the formula CH~3~CHO, is a highly reactive compound that causes DNA damage \[[@B1-ijms-18-01943],[@B2-ijms-18-01943]\]. It is found in food and drinks such as yogurt, ripe fruits, cheese, coffee, and alcoholic beverages \[[@B3-ijms-18-01943],[@B4-ijms-18-01943]\], and in tobacco smoke \[[@B5-ijms-18-01943]\]. In addition, acetaldehyde can be produced by microorganisms such as yeasts and bacteria in the human oral cavity \[[@B6-ijms-18-01943],[@B7-ijms-18-01943],[@B8-ijms-18-01943]\]. Thus, acetaldehyde can be ingested orally in a variety of ways. In particular, alcoholic beverages such as Calvados and other spirits contain high quantities of "free" acetaldehyde (e.g., Calvados: 1781 ± 861 μM), and frequent consumption of these beverages is associated with an increased risk of esophageal squamous cell carcinoma (ESCC) \[[@B4-ijms-18-01943],[@B9-ijms-18-01943]\], although "free" acetaldehyde present in alcoholic beverages appears to cause only a short time (1--2 min) direct exposure to the organs \[[@B10-ijms-18-01943]\].

More importantly, acetaldehyde is also generated endogenously by alcohol metabolism. Ingested alcohol is absorbed from the upper gastrointestinal tract and transported to the liver, where it is mainly metabolized into acetaldehyde by alcohol dehydrogenase 1B (ADH1B), and then detoxified to acetic acid by aldehyde dehydrogenase 2 (ALDH2) ([Figure 1](#ijms-18-01943-f001){ref-type="fig"}) \[[@B11-ijms-18-01943],[@B12-ijms-18-01943]\]. Genetic polymorphisms in *ADH1B* and/or *ALDH2* can result in different enzymatic activities that have a major impact on the risk of ESCC as well as head and neck squamous cell carcinoma (HNSCC) \[[@B13-ijms-18-01943],[@B14-ijms-18-01943],[@B15-ijms-18-01943],[@B16-ijms-18-01943]\].

ADH1B has two alleles, *ADH1B\*1* (less active ADH1B) and *ADH1B\*2* (active ADH1B, Arg47His). Therefore, ADH1B is divided into three genotypes; *ADH1B\*1*/*\*1*, less active slow metabolizing ADH1B, and *ADH1B\*1*/*\*2* and *ADH1B\*2*/*\*2*, active ADH1B \[[@B17-ijms-18-01943]\]. Since alcohol metabolism is slow in individuals homozygous for *ADH1B\*1/\*1*, acetaldehyde remains in the body for a long time. Meta-analysis has shown that individuals with *ADH1B\*1/\*1* have a 2.77- and 2.35-fold increased risk of ESCC \[[@B18-ijms-18-01943]\] and HNSCC \[[@B19-ijms-18-01943]\], respectively, compared with carriers of the *ADH1B\*2* allele (*ADH1B\*1/\*2* and *ADH1B\*2/\*2*).

ALDH2 has two alleles, *ALDH2\*1* (active ALDH2) and *ALDH2\*2* (inactive ALDH2, Glu504Lys). As ALDH2 is a tetrameric enzyme and *ALDH2\*2* acts in a dominant negative manner, the phenotypic loss of ALDH2 activity is found in both heterozygous (*ALDH2\*1*/*\*2*) and homozygous (*ALDH2\*2*/*\*2*) genotypes \[[@B20-ijms-18-01943],[@B21-ijms-18-01943]\]. Subsequently, ALDH2 genotypes are classified as follows: *ALDH2\*1*/*\*1*, active (100% activity) ALDH2; *ALDH2\*1*/*\*2*, inactive (\< 10% activity) ALDH2; and *ALDH2\*2/\*2*, inactive (0% activity) ALDH2 \[[@B22-ijms-18-01943]\]. Carriers of the *ALDH2\*2* allele (*ALDH2\*1*/*\*2* and *ALDH2\*2*/*\*2*) account for approximately 40% of East Asian populations \[[@B23-ijms-18-01943],[@B24-ijms-18-01943],[@B25-ijms-18-01943]\], whereas these genotypes are quite rare in Caucasoid or Negroid populations \[[@B26-ijms-18-01943]\]. Meta-analysis has shown that individuals with *ALDH2\*1*/*\*2* have a 7.12- and 1.83-fold increased risk of ESCC \[[@B14-ijms-18-01943]\] and HNSCC \[[@B27-ijms-18-01943]\], respectively, compared with carriers of *ALDH2\*1*/*\*1.* Moreover, alcoholics with the *ALDH2\*1*/*\*2* genotype have a 13.5- and 18.52-fold increased risk of ESCC and HNSCC, respectively, compared with *ALDH2\*1*/*\*1* genotypes \[[@B15-ijms-18-01943]\].

Thus, extensive epidemiological evidence suggests that acetaldehyde is deeply involved in the carcinogenesis of the squamous epithelium of the esophagus, and head and neck. In addition, the International Agency for Research on Cancer has defined acetaldehyde associated with the consumption of alcoholic beverages as a "group 1 carcinogen" (definite carcinogen) for the esophagus and/or head and neck \[[@B28-ijms-18-01943]\].

2. Field Cancerization in the Esophagus, and Head and Neck {#sec2-ijms-18-01943}
==========================================================

In some patients, ESCC occurs synchronously and/or metachronously in conjunction with HNSCC ([Figure 2](#ijms-18-01943-f002){ref-type="fig"}A) \[[@B12-ijms-18-01943],[@B29-ijms-18-01943]\]. In such patients, widespread epithelial oncogenic alterations are frequently observed in the esophagus and can be visible as multiple Lugol-voiding lesions (LVLs) by Lugol chromoendoscopy ([Figure 2](#ijms-18-01943-f002){ref-type="fig"}B) \[[@B30-ijms-18-01943],[@B31-ijms-18-01943]\]. Thus, multiple occurrences of neoplastic changes in the upper aerodigestive tract have been explained by the phenomenon of "field cancerization" \[[@B32-ijms-18-01943]\]. We reported previously that the *ALDH2\*2* allele is the strongest contributing factor (OR: 17.6) for the development of multiple LVLs \[[@B29-ijms-18-01943]\]. Our recent prospective cohort study also revealed that the severity of LVLs is associated with the amount of average alcohol consumption, and individuals with multiple LVLs in their esophagus are especially at high risk for metachronous multiple ESCC and HNSCC \[[@B33-ijms-18-01943]\]. Thus, alcohol consumption in individuals with the *ALDH2\*2* allele is proven to be associated with the development of field cancerization in the esophagus, and head and neck.

3. Blood and Salivary Acetaldehyde Level after Alcohol Intake {#sec3-ijms-18-01943}
=============================================================

Alcohol consumption increases acetaldehyde concentrations in the blood, saliva, and breath \[[@B29-ijms-18-01943],[@B34-ijms-18-01943],[@B35-ijms-18-01943]\]. In particular, acetaldehyde concentration reaches a very high level in saliva compared with blood \[[@B6-ijms-18-01943]\]. When *ALDH2\*1*/*\*1* or *ALDH2\*1*/*\*2* carriers drink 0.6 g ethanol/kg body weight, salivary acetaldehyde concentrations immediately reach 24 to 53 μM in *ALDH2\*1*/*\*1* carriers and 37 to 76 μM in *ALDH2\*1*/*\*2* carriers, respectively \[[@B36-ijms-18-01943]\]. The reason for the high acetaldehyde concentrations in saliva is considered to be associated with the formation of acetaldehyde from ethanol via microbial \[[@B6-ijms-18-01943]\] and/or mucosal ADH \[[@B37-ijms-18-01943]\]. Moreover, secretion from salivary glands also influences acetaldehyde concentration in saliva. Indeed, alcohol drinking (0.5 g ethanol/kg body weight) increases acetaldehyde concentrations in parotid duct saliva on *ALDH2\*1*/*\*2* carriers, while it does not affect those on *ALDH2\*1*/*\*1* carriers \[[@B38-ijms-18-01943]\]. Furthermore, breath acetaldehyde is also thought to dissolve into saliva. The acetaldehyde concentrations in the oral cavity thus produced are equivalent to the concentration that can induce DNA damage in vitro \[[@B6-ijms-18-01943],[@B38-ijms-18-01943]\]. Therefore, alcohol consumption in *ALDH2\*1*/*\*2* carriers could promote the direct contact of high acetaldehyde-containing saliva to the surface of the oropharynx, hypopharynx, and esophagus and has the potential to induce DNA damage in the squamous epithelium. Taken together, sustained high acetaldehyde-containing saliva is considered to play an important role in the carcinogenesis of upper digestive tract cancers and it could be involved in "field cancerization."

4. Acetaldehyde Reacts with DNA to Form DNA Adducts {#sec4-ijms-18-01943}
===================================================

Acetaldehyde reacts directly with the exocyclic amino group of deoxyguanosine (dG) to form DNA adducts such as *N^2^*-ethylidene-2′-deoxyguanosine (*N^2^*-ethylidene-dG) \[[@B39-ijms-18-01943]\], *N^2^*-ethyl-2′-deoxyguanosine (*N^2^*-Et-dG) \[[@B40-ijms-18-01943],[@B41-ijms-18-01943]\], and α-*S*- and α-*R*-methyl-γ-hydroxy-1, *N^2^*-propano-2′-deoxyguanosine (CrPdG) ([Figure 3](#ijms-18-01943-f003){ref-type="fig"}) \[[@B39-ijms-18-01943],[@B42-ijms-18-01943]\].

*N^2^*-ethylidene-dG is generated by a single molecule of acetaldehyde and is the most abundant DNA adduct derived from acetaldehyde \[[@B43-ijms-18-01943]\]. *N^2^*-ethylidene-dG is unstable at the nucleoside level and is therefore difficult to measure \[[@B39-ijms-18-01943]\]. *N^2^*-ethylidene-dG can be stabilized by the chemical reduction of the Schiff base to the stable product, *N^2^*-Et-dG. As endogenous *N^2^*-Et-dG is extremely low, the level of *N^2^*-Et-dG that is converted from *N^2^*-ethylidene-dG by chemical reduction (e.g., NaBH~3~CN) indicates the endogenous *N^2^*-ethylidene-dG level \[[@B44-ijms-18-01943]\]. Thus, *N^2^*-ethylidene-dG is used for analysis of acetaldehyde-mediated DNA damage \[[@B43-ijms-18-01943],[@B45-ijms-18-01943],[@B46-ijms-18-01943]\] as a biomarker for acetaldehyde-specific DNA damage \[[@B47-ijms-18-01943]\]. Indeed, alcohol consumption increases oral *N^2^*-ethylidene-dG levels \[[@B48-ijms-18-01943],[@B49-ijms-18-01943]\]. Furthermore, blood *N^2^*-ethylidene-dG levels are definitely increased by alcohol consumption \[[@B50-ijms-18-01943]\] and/or tobacco smoking \[[@B51-ijms-18-01943]\]. Additionally, blood *N^2^*-ethylidene-dG levels in alcoholics with the *ALDH2\*2* allele are higher than those with the *ALDH2\*1*/*\*1* allele \[[@B46-ijms-18-01943]\]. Importantly, alcohol consumption increases the esophageal *N^2^*-ethylidene-dG levels in *Aldh2*-knockout mice to a higher level than that of wild-type mice \[[@B47-ijms-18-01943],[@B52-ijms-18-01943]\]. This evidence indicates that drinking alcohol definitely increases acetaldehyde exposure to the esophageal tissues in individuals with the *ALDH2\*2* allele.

CrPdG is generated by the reaction of two molecules of acetaldehyde with DNA \[[@B53-ijms-18-01943]\] and exists in a ring-opened or ring-closed form \[[@B54-ijms-18-01943],[@B55-ijms-18-01943]\]. Here, two molecules of acetaldehyde are converted into crotonaldehyde and then react with DNA to form CrPdG \[[@B56-ijms-18-01943]\]. The levels of CrPdG are also related to the amount of acetaldehyde produced \[[@B57-ijms-18-01943]\].

An ethenobase adduct, 1,*N^2^*-etheno-2′-deoxyguanosine (NεG), is generated in human cells treated with acetaldehyde \[[@B53-ijms-18-01943]\]. NεG is a product from 2′-deoxyguanosine and α,β-unsaturated aldehydes that can be formed during lipid peroxidation mediated by acetaldehyde ([Figure 3](#ijms-18-01943-f003){ref-type="fig"}) \[[@B53-ijms-18-01943],[@B58-ijms-18-01943]\]. As acetaldehyde induces reactive oxygen species (ROS) that leads to lipid peroxidation \[[@B59-ijms-18-01943]\], generation of NεG can be triggered by acetaldehyde, ROS, or both.

5. DNA Adducts Induce Severe DNA Damage {#sec5-ijms-18-01943}
=======================================

*N^2^*-Et-dG blocks DNA synthesis and induces DNA mutations \[[@B60-ijms-18-01943],[@B61-ijms-18-01943],[@B62-ijms-18-01943],[@B63-ijms-18-01943]\]. Moreover, *N^2^*-Et-dG inhibits translesion DNA synthesis (TLS), which leads to a majority of frameshift deletions and a minority of G:C \> T:A transversions in human cells \[[@B62-ijms-18-01943]\]. *N^2^*-Et-dG can rotate around the exocyclic nitrogen and the alpha carbon of acetaldehyde because it has a single bond, whereas *N^2^*-ethylidene-dG has a double bond, which makes it more hydrophobic than *N^2^*-Et-dG. These differences may result in significantly different mutagenic potential between *N^2^*-Et-dG and *N^2^*-ethylidene-dG \[[@B2-ijms-18-01943]\].

CrPdG induces DNA interstrand \[[@B64-ijms-18-01943]\] and intrastrand cross-links \[[@B65-ijms-18-01943]\]. The ring-opened form of CrPdG can react with dG on the opposite strand of the DNA to form DNA interstrand cross-links \[[@B66-ijms-18-01943]\]. A similar mechanism has been suggested for the formation of DNA intrastrand cross-links \[[@B2-ijms-18-01943]\]. Whereas the ring-closed form of CrPdG would prevent Watson--Crick base pairing with cytosine in the anti conformation, Hoogsteen base pairing with cytosine would be possible in the *syn* conformation \[[@B55-ijms-18-01943]\]. CrPdG-mediated disruption of the DNA replication process is thought to cause DNA damage \[[@B55-ijms-18-01943],[@B67-ijms-18-01943],[@B68-ijms-18-01943],[@B69-ijms-18-01943]\].

NεG inhibits a replicative polymerase δ in complex with proliferating cell nuclear antigen (PCNA) while translesion polymerases η, ι, and κ can bypass the lesion with varying mutagenic consequences \[[@B70-ijms-18-01943],[@B71-ijms-18-01943],[@B72-ijms-18-01943]\]. In cells, replication of a plasmid containing a site-specific NεG induces base-pair mutations at the NεG site as well as deletions, rearrangements, double mutants, and base-pair substitutions near the NεG site \[[@B73-ijms-18-01943]\]. These mutations near the NεG site could be triggered by error-prone processing of DNA double-strand breaks (DSBs) resulting from a replication fork collapse caused by NεG \[[@B2-ijms-18-01943]\]. Certainly, acetaldehyde blocks DNA replication and increases the level of phosphorylated histone H2AX (γ-H2AX), a DSB marker, in cells \[[@B74-ijms-18-01943]\].

Acetaldehyde exposure of human cells increases rates of sister chromatid exchange (SCE) \[[@B75-ijms-18-01943]\]. SCE is thought to result from replication-blocking DNA lesions \[[@B76-ijms-18-01943]\]. Although CrPdGs, NεG, and interstrand cross-links are shown to inhibit replication, the adducts or cross-links that relate to the formation of SCEs have not been elucidated.

6. Carcinogenic Effects of Acetaldehyde {#sec6-ijms-18-01943}
=======================================

To elaborate on details mentioned previously in part, acetaldehyde causes DNA adducts \[[@B39-ijms-18-01943],[@B40-ijms-18-01943],[@B41-ijms-18-01943],[@B42-ijms-18-01943]\], DNA single-strand breaks, DSBs \[[@B77-ijms-18-01943]\], point mutations \[[@B69-ijms-18-01943]\], SCEs \[[@B78-ijms-18-01943],[@B79-ijms-18-01943],[@B80-ijms-18-01943]\], DNA--DNA cross-links \[[@B81-ijms-18-01943]\], micronuclei \[[@B82-ijms-18-01943]\], and gross chromosomal aberrations \[[@B65-ijms-18-01943],[@B80-ijms-18-01943]\]. Accumulations of these genetic abnormalities are considered to proceed cancer development. Exposure of acetaldehyde directly induces mutations, most frequently G:C \> A:T transitions in the TP53 gene \[[@B83-ijms-18-01943]\]. This transition pattern is consistent with that found in a study of the HPRT reporter gene \[[@B69-ijms-18-01943]\]. In addition, G:C \> T:A transversions are the most frequent miscoding events induced by CrPdG, followed by G:C \> C:G and G:C \> A:T mutations \[[@B67-ijms-18-01943],[@B68-ijms-18-01943],[@B69-ijms-18-01943]\]. This spectrum of mutations corresponds with the gene variation pattern observed in ESCC \[[@B84-ijms-18-01943],[@B85-ijms-18-01943]\] and HNSCC \[[@B86-ijms-18-01943]\]. Furthermore, inhalation of acetaldehyde causes nasal and respiratory squamous cell carcinoma in rats and hamsters \[[@B87-ijms-18-01943],[@B88-ijms-18-01943]\]. These results indicate that acetaldehyde has direct carcinogenic effects in animals.

7. Repair Pathways of Acetaldehyde-Mediated DNA Damage {#sec7-ijms-18-01943}
======================================================

Recent research has revealed that cells coordinate multiple processes, such as the Fanconi anemia (FA) pathway, nucleotide excision repair (NER), homologous recombination (HR), TLS, base excision repair (BER), fork protection complex, and ATR-dependent cell cycle checkpoint activation, to prevent and repair acetaldehyde-mediated DNA damage \[[@B89-ijms-18-01943]\].

The specific repair processes for *N^2^*-ethylidene-dG and *N^2^*-Et-dG remain unknown. The efforts to identify the repair mechanism for *N^2^*-Et-dG are reported to be unsuccessful \[[@B2-ijms-18-01943],[@B90-ijms-18-01943]\].

The most plausible repair pathway of CrPdG is NER \[[@B91-ijms-18-01943]\]. CrPdG generates interstrand cross-links \[[@B64-ijms-18-01943]\], which can be repaired by the FA pathway \[[@B2-ijms-18-01943]\]. This pathway is composed of at least 19 genes *(FANCA*, *B*, *C*, *D1*, *D2*, *E--G*, *I*, *J*, *L--T*) and the deficiency of these genes can cause FA \[[@B92-ijms-18-01943]\]. FANCA, B, C, E--G, L, and M form a core complex at the site of interstrand cross-links and then promote ubiquitination of the FANCD2--FANCI complex. This ubiquitination leads to the activation of downstream effector proteins, FANCD1, O, P, and Q. They promote the nucleolytic processing of interstrand cross-links, followed by DNA repair via HR \[[@B93-ijms-18-01943],[@B94-ijms-18-01943],[@B95-ijms-18-01943],[@B96-ijms-18-01943],[@B97-ijms-18-01943]\]. Indeed, the FA--BRCA network is activated when cells are treated with ethanol or aldehyde \[[@B98-ijms-18-01943],[@B99-ijms-18-01943]\]. Cells derived from an FA patient are hypersensitive to acetaldehyde exposure \[[@B99-ijms-18-01943],[@B100-ijms-18-01943]\]. Cells deficient for FANCG, FANCQ, or HR protein Rad51D also show many chromosomal aberrations in response to acetaldehyde, while cells deficient for BER and nonhomologous end-joining show subtle increases in chromosome aberration \[[@B101-ijms-18-01943],[@B102-ijms-18-01943]\]. In vivo, when mice with disrupted *Aldh2* locus (*Aldh2*^+/−^ or *Aldh2*^−/−^) and *Fancd2* heterozygosity (*Fancd2*^+/−^) are crossed and then challenged with ethanol exposure, the numbers of double-knockout offspring (*Aldh2*^−/−^, *Fancd2*^−/−^) are significantly reduced \[[@B103-ijms-18-01943]\]. Treatment with ethanol in adult double-knockout mice (*Aldh2*^−/−^, *Fancd2*^−/−^) results in dramatic reductions of bone marrow cells. Moreover, these mice develop leukemia, even without ethanol administration \[[@B103-ijms-18-01943]\]. These results indicate that Fancd2 plays an important role in the protection from acetaldehyde-induced genotoxicity.

Acetaldehyde-mediated DSB is repaired by HR \[[@B74-ijms-18-01943]\]. Acetaldehyde accumulates γ-H2AX, which colocalizes with foci of the HR protein Rad51 in cells \[[@B74-ijms-18-01943]\]. Moreover, recombination-defective cells are hypersensitive to acetaldehyde \[[@B74-ijms-18-01943]\].

8. Prevention of Acetaldehyde-Mediated DNA Damage {#sec8-ijms-18-01943}
=================================================

Acetaldehyde-mediated DNA damage is influenced by ALDH2 expression level \[[@B52-ijms-18-01943]\]. ALDH2 is known to express in various tissues including the liver, kidney, muscle, and heart \[[@B104-ijms-18-01943]\]. Recently, we found that alcohol consumption in mice promoted ALDH2 protein production in esophageal epithelium \[[@B52-ijms-18-01943]\]. In vitro experiments revealed that ALDH2 is induced by acetaldehyde exposure in esophageal keratinocytes. ALDH2 knockdown resulted in an increase of susceptibility to acetaldehyde. Conversely, ALDH2 overexpression prevented acetaldehyde-mediated DNA damage in esophageal keratinocytes, although overexpression of mutant ALDH2 (*ALDH2\*2*) offered no protection. Thus, enhancement of ALDH2 expression level may prevent acetaldehyde-mediated DNA damage.

9. Conclusions {#sec9-ijms-18-01943}
==============

Previous studies have provided substantial evidence that acetaldehyde induces various forms of DNA damage leading to cancer development ([Figure 4](#ijms-18-01943-f004){ref-type="fig"}). DNA adduct formation might be the key to acetaldehyde-mediated DNA damage; however, the role of DNA adducts in carcinogenesis has not been completely elucidated. Further studies are necessary to reveal the complete mechanisms of acetaldehyde-mediated cancer development.
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![Ethanol and acetaldehyde metabolism after alcohol ingestion. Ethanol is metabolized to acetaldehyde by alcohol dehydrogenase 1B (ADH1B), and then acetaldehyde is degraded to acetic acid by aldehyde dehydrogenase 2 (ALDH2).](ijms-18-01943-g001){#ijms-18-01943-f001}

![Lugol chromoendoscopic images. (**A**): "Field cancerization" in a patient with esophageal squamous cell carcinoma (ESCC) and head and neck squamous cell carcinoma (HNSCC) synchronously. Location of (**a**) oropharynx, (**b**) uvula, (**c**) upper thoracic esophagus, and (**d**) lower thoracic esophagus. Lesions are indicated by arrowheads; (**B**): (**a**) normal esophageal mucosa, (**b**) esophageal mucosa with multiple dysplastic lesions known as multiple Lugol-voiding lesions. Scale bar = 0.5 cm.](ijms-18-01943-g002){#ijms-18-01943-f002}

![Formation of acetaldehyde-mediated DNA adducts. A single molecule of acetaldehyde reacts with deoxyguanosine (dG) to generate *N^2^*-ethylidene-2′-deoxyguanosine (*N^2^*-ethylidene-dG), which can be reduced to the stable adducts, *N^2^*-ethyl-2′-deoxyguanosine (*N^2^*-Et-dG). α-*S*- and α-*R*-methyl-γ-hydroxy-1, *N^2^*-propano-2′-deoxyguanosine (CrPdG) is derived from dG and two molecules of acetaldehyde. *N^2^*-etheno-2′-deoxyguanosine (NεG) is formed from dG and α,β-unsaturated aldehydes during lipid peroxidation, which is mediated by acetaldehyde or reactive oxygen species (ROS).](ijms-18-01943-g003){#ijms-18-01943-f003}

![Summary of acetaldehyde-mediated DNA damage. Acetaldehyde causes DNA adducts, DNA single-strand breaks, DNA double-strand breaks (DSBs), point mutations, micronuclei, frameshift mutations, base-pair mutations, deletions, DNA--DNA interstrand or intrastrand cross-links, rearrangements, and sister chromatid exchanges (SCEs). DNA adducts are considered to be partly (but deeply) involved in their formation.](ijms-18-01943-g004){#ijms-18-01943-f004}
